| HOME >> MEDICINE >> TECHNOLOGY |
ELECTRONIC DATA CAPTURE (EDC) 33
CLINICAL TRIAL COSTS 34
FACTORS INFLUENCING CLINICAL TRIAL COSTS 34
Factors Increasing Clinical Trial Costs 34
Factors Increasing Clinical … (Continued) 35
Factors Decreasing Clinical Trial Costs 36
RECENT AND FUTURE TRENDS IN CLINICAL TRIAL PROCESSES 36
RESEARCH AND DEVELOPMENT BUDGETS 36
TABLE
INVESTMENT IN R&D AS A PERCENT OF SALES, PHARMACEUTICAL INDUSTRY, THROUGH 2014 (%) 37
TABLE 11 INVESTMENT IN R&D AS A PERCENT OF SALES, PHARMACEUTICAL INDUSTRY, THROUGH 2014, PHRMA MEMBERS, (%) 37
FUNDING CLINICAL TRIALS 38
TABLE 12
TOTAL R&D SPENDING BY SOURCE, THROUGH 2014 ($ BILLIONS) 39
TABLE 13
ESTIMATES OF NIH RESEARCH FUNDING FOR TOP 50 CONDITIONS AND DISEASE CATEGORIES, RESEARCH/DISEASE AREAS, THROUGH 2010 ($ MILLIONS/ROUNDED) 40
BIOTECH/PHARMACEUTICAL COMPANIES 41
TABLE 14 U.S. MARKET FORECAST OF REGISTERED CLINICAL TRIALS SPONSORED BY INDUSTRY BY PHASE, THROUGH 2014 (RECRUITING SUBJECTS) 42
NATIONAL INSTITUTES OF HEALTH AND OTHER FEDERAL AGENCIES OF THE FEDERAL GOVERNMENT 42
TABLE 15
U.S. MARKET FORECAST OF REGISTERED CLINICAL TRIALS SPONSORED BY FEDERAL GOVERNMENT BY PHASE, THROUGH 2014 (RECRUITING SUBJECTS) 43
PRIVATE ORGANIZATIONS, UNIVERSITIES, AND SPECIALTY GROUPS 43
TABLE 16 U.S. MARKET FORECAST OF REGISTERED CLINICAL TRIALS SPONSORED BY UNIVERSITIES OR OTHER ORGANIZATIONS BY PHASE, THROUGH 2014 (RECRUITING SUBJECTS) 44
TABLE 17 TOP 25 FOUNDATIONS AWARDING U.S.-FOCUSED GRANTS FOR GLOBAL HEALTH, RANKED BY NUMBER OF GRANTS AND DOLLAR AMOUNT, 2008 44
Private Organizations, Universities… (Continued) 45
Chapter-5: CLINICAL TRIAL PIPELINES AND TECHNOLOGY TRENDS
DRUGS BY SYSTEM 46
CARDIOVASCULAR 46
PhRMA Facts 46
PhRMA Facts (Continued) 47
TABLE 18 SEL
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |